Palantir Technologies
PLTR
$160.38
+3.48%
Palantir Technologies is an artificial intelligence and data-analytics software company whose Foundry and Gotham platforms help commercial enterprises and Western-allied governments turn sprawling datasets into operational decisions, competing in the software-infrastructure and enterprise AI market. It occupies a distinctive position as a high-touch, forward-deployed engineering partner rather than a pure self-serve SaaS vendor, a model that has historically drawn comparisons to consulting firms even as its gross margins and scalability increasingly resemble elite software economics. The current investor debate centers on whether Palantir's extraordinary growth acceleration — U.S. revenue reportedly up 119% with commercial revenue surpassing government revenue for the first time — justifies one of the richest multiples in the entire technology universe, particularly after Q3 results showed strong revenue growth but flat remaining performance obligations and a sharp slowdown in total contract-value growth. Sentiment has become a tug-of-war between bulls who see Palantir as the defining sovereign-AI franchise and skeptics, including some vocal sell-side voices, who warn that extreme valuation and governance concerns leave the stock vulnerable to a severe drawdown.…
PLTR
Palantir Technologies
$160.38
Related headlines
Investment Opinion: Should I buy PLTR Today?
Rating: Hold with a constructive bias. Palantir is a genuinely exceptional business — 95.87% revenue growth, 83.43% gross margin, 48.76% net margin, $4.054 billion of TTM free cash flow, and debt-to-equity of just 0.031 — but at $175.40 the stock already discounts years of flawless execution, and the 22 Buy / 9 Hold / 2 Sell split with a 1.85 recommendation mean and a $216.00 average target (roughly 23% upside) frames the debate as 'great company, demanding price' rather than 'mispriced asset.' The core thesis is that Palantir's commercial inflection — Commercial revenue of $1.168 billion surpassing Government's $1.146 billion for the first time, with U.S. revenue up 119% — is real and durable, but the Q3 flat RPO and slowing total contract-value growth mean the next two quarters must re-accelerate bookings before the multiple can be defended.
Supporting evidence cuts both ways. On the positive side: revenue compounded from $1.181 billion in Q3 2025 to $2.313 billion in Q3 2026 (+95.87%), EPS rose from $0.26 in Q4 2025 to $0.47 in Q3 2026, operating margin expanded from 33.30% in Q3 2025 to 46.89% in Q3 2026, and the PEG ratio of 1.13 is the one valuation metric that looks almost reasonable against a 96% growth rate. On the negative side: 94.1x sales, 68.1x EV/Sales, 57.0x book, 249.5x EV/EBITDA and 257.6x trailing earnings dwarf the 10–20x sales norm for high-growth software, and the forward PE of 70.7x versus trailing 257.6x requires earnings to roughly quadruple — a bet on consensus EPS of $14.38 that leaves no room for a bookings stumble. The $216 average target implies 23% upside, but the $80 low target implies roughly 54% downside, so the risk/reward is roughly 1:2.3 in magnitude terms even though the probability-weighted skew favors the base case.
Three risks could invalidate the thesis: (1) bookings confirmation of a peak — if RPO stays flat and contract-value growth keeps decelerating in Q4, the growth premium collapses; (2) multiple compression in AI software, already visible in the October 16 sector selloff and the stock's 7.07% one-month decline versus the S&P 500's -1.99%; and (3) dilution, with stock-based compensation of $318.9 million in Q3 and shares outstanding rising from 2.304 billion in Q4 2024 to 2.406 billion in Q3 2026. This Hold would upgrade to Buy on a pullback toward the $140–150 zone (roughly 60–65x sales) or on a Q4 re-acceleration in RPO and contract value; it would downgrade to Sell if revenue growth decelerates below 50% or if gross margin breaks below the 80% floor. Verdict: fairly valued to modestly overvalued relative to peers and its own history — the 94.1x PS sits well below the 2025 peak of over 365x but far above the 2022–2023 trough near 26x, and the PEG of 1.13 argues the premium is growth-justified rather than irrational.
Sign up to view all
PLTR 12-Month Price Forecast
Palantir presents a classic quality-versus-price tension: the fundamentals are among the best in software — 95.87% growth, 83.43% gross margin, 48.76% net margin, $4.054 billion TTM free cash flow, and a near-debt-free balance sheet — but the 94.1x sales multiple already capitalizes much of that excellence, and the flat RPO plus slowing contract-value growth is the first credible crack in the growth narrative. The 22/9/2 Buy/Hold/Sell split and 1.85 recommendation mean reflect a Street that likes the company but is unwilling to chase the stock, and the 231% spread between the $80 low and $265 high targets quantifies how little consensus exists on fair value. The base case (50% probability, $195–$220) assumes growth moderates gracefully and the stock converges toward the $216 average target through earnings growth rather than multiple expansion, while the bear case (25%, $80–$130) hinges entirely on bookings confirming a peak. I would upgrade to bullish if Q4 RPO and contract value re-accelerate or if the stock pulls back toward $140–150 (roughly 60–65x sales); I would downgrade to bearish if revenue growth decelerates below 50% or gross margin breaks below 80%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Palantir Technologies's 12-month outlook, with a consensus price target around $222.25 and implied upside of +38.6% versus the current price.
Average Target
$222.25
33 analysts
Implied Upside
+38.6%
vs. current price
Analyst Count
33
covering this stock
Price Range
$80 - $273
Analyst target range
Palantir is covered by 28 analysts with a Buy/Hold/Sell distribution of 22/9/2, yielding a consensus recommendation of "buy" and a recommendation mean of 1.85 (where 1.0 is a strong buy). The average target price of $216.00 implies roughly 23% upside from the current $175.40, a constructive signal that the Street still sees meaningful appreciation despite the stock's recent stumble. Sentiment is bullish but not euphoric, with the nine Hold ratings and two Sells reflecting genuine valuation anxiety — a tension echoed by recent institutional actions, including Goldman Sachs' upgrade to Buy with a $230 target alongside RBC Capital's persistent Underperform rating and Morgan Stanley's Equal Weight stance.\n\nThe target range is exceptionally wide, spanning from a low of $80.00 to a high of $265.00 — a 231% spread that signals unusually high uncertainty and deep disagreement about Palantir's fair value. The $265 high target assumes continued hyper-growth, commercial-segment dominance, and multiple expansion on sovereign-AI leadership, while the $80 low target effectively prices in a severe de-rating, margin compression, or a growth stall as contract-value momentum fades. Recent rating activity has been mostly reiterations rather than fresh upgrades or downgrades, suggesting analysts are in a holding pattern awaiting clearer evidence on whether the Q3 deceleration in bookings is a blip or the start of a slowdown — and with consensus revenue estimates of $70.1 billion against a $421 billion market cap, the stock's fate hinges on whether Palantir can convert its extraordinary growth into the earnings the forward multiple demands.
Drowning in data?
Find the real signal!
Bulls vs Bears: PLTR Investment Factors
The bull case currently rests on stronger hard evidence: 95.87% revenue growth, 83.43% gross margins, 48.76% net margins, $4.054 billion of TTM free cash flow, and a near-debt-free balance sheet are exceptional and verifiable, and the commercial segment overtaking government diversifies the revenue base. The bear case is almost entirely about price and forward visibility — 94.1x sales and 257.6x trailing earnings leave no margin for error, and flat RPO plus slowing contract-value growth is the first crack in the growth narrative. On balance the fundamental evidence favors the bulls, but the valuation evidence favors the bears, which is why the consensus sits at 'buy' with a 1.85 mean rather than a strong buy. The single most important tension is whether the Q3 bookings deceleration is a blip or the start of a slowdown: if RPO and contract value re-accelerate next quarter, the multiple is defensible and the $216 average target looks achievable; if they confirm a peak, the stock's 48% drawdown capacity becomes very relevant.
Bullish
- Hyper-growth with commercial inflection: Q3 2026 revenue hit $2.313 billion, up 95.87% year over year from a $1.181 billion base, and the Commercial segment at $1.168 billion surpassed Government's $1.146 billion for the first time. U.S. revenue reportedly grew 119%, showing the acceleration is concentrated in the largest, most profitable market rather than a one-off defense-budget bump.
- Elite software margins, not consulting economics: Gross margin of 83.43% and operating margin of 46.89% in Q3 2026 are squarely in best-in-class software territory, refuting the 'consulting company' critique. Net margin of 48.76% and TTM free cash flow of $4.054 billion demonstrate that growth is being converted into cash at scale.
- Fortress balance sheet removes solvency risk: Debt-to-equity of just 0.031, a current ratio of 7.11, and $3.653 billion of cash mean Palantir carries essentially no leverage risk. ROE of 22.0% and ROA of 17.3% confirm high capital efficiency on top of the cash cushion.
- Analyst consensus still constructive: Of 28 analysts, 22 rate Buy against 9 Hold and 2 Sell, for a recommendation mean of 1.85 and a consensus 'buy'. The $216 average target implies roughly 23% upside from $175.40, and Goldman Sachs' upgrade to Buy with a $230 target shows conviction is still building on the sovereign-AI thesis.
Bearish
- Extreme absolute valuation multiples: At 94.1x sales, 68.1x EV/Sales, 57.0x book, and 249.5x EV/EBITDA, Palantir trades at roughly five to nine times typical high-growth software averages of 10-20x sales. The 257.6x trailing PE means the market is paying for flawless multi-year compounding, leaving little room for any execution stumble.
- Bookings momentum is decelerating: Q3 results showed flat remaining performance obligations and a sharp slowdown in total contract-value growth, which is why the stock fell despite 95.87% revenue growth. Since RPO is the leading indicator for future revenue, flat RPO raises the question of whether 96% growth is a peak rather than a sustainable plateau.
- Severe drawdown history and high beta: The stock has a 48.22% maximum drawdown and a beta of 1.61, meaning it is roughly 61% more volatile than the S&P 500. It is already down 15.34% over the trailing year and 7.07% over the past month, lagging the index by 25.73 and 5.08 percentage points respectively over those windows.
- Wide analyst dispersion signals uncertainty: Targets span $80 to $265, a 231% spread, with RBC maintaining Underperform and Morgan Stanley Equal Weight even as Goldman turns bullish. That divergence reflects genuine disagreement about fair value, and the $80 low target implies roughly 54% downside from the current $175.40.
PLTR Technical Analysis
Palantir is in a volatile, range-bound consolidation rather than a clean trend, with the stock down 15.34% over the trailing year despite a powerful 27.98% six-month advance and a modest 4.49% year-to-date gain. At $175.40, the shares sit roughly 69% of the way through a wide 52-week range bounded by a $106.37 low and a $212.94 high, positioning them in the upper-middle of the band — not near breakout territory, but far from distressed levels. The 48.22% maximum drawdown underscores how violently this name can retrace even within an otherwise constructive longer-term structure.\n\nShort-term momentum has clearly decelerated: the stock is down 7.07% over the past month versus a 10.71% gain over three months, a sharp negative divergence that signals the August–October advance is being digested. Relative strength tells the same story — PLTR has lagged the S&P 500 by 5.08 percentage points over one month and 25.73 points over a year, yet it has outperformed the index by 12.72 points over three months and 24.87 points over six months, confirming that the recent weakness is a pullback within a stronger intermediate uptrend rather than a structural breakdown. The most recent sessions reinforce the fade, with the stock sliding from $184.11 on October 30 to $175.40 on November 3, a 4.7% three-session decline on elevated volume of roughly 53.1 million shares.\n\nKey technical levels are well defined: support clusters near the $162–$166 zone (the early-August breakout shelf) and, more critically, the $106.37 52-week low, while resistance sits at the $209–$213 area where the stock stalled in mid-October and again near the $212.94 high. A decisive break above $213 would confirm a fresh leg higher and likely re-open momentum-chasing flows, whereas a loss of $162 would threaten the six-month uptrend and put the $106 low back in play. With a beta of 1.61, Palantir is roughly 61% more volatile than the S&P 500, meaning position sizing should be materially smaller than a market-weight allocation and stop-loss discipline is essential given the stock's demonstrated capacity for 48% peak-to-trough drawdowns.
Beta
1.61
1.61x market volatility
Max Drawdown
-48.2%
Largest decline past year
52-Week Range
$106-$213
Price range past year
Annual Return
-8.4%
Cumulative gain past year
| Period | PLTR Return | S&P 500 |
|---|---|---|
| 1m | -17.4% | -5.0% |
| 3m | -6.8% | -4.9% |
| 6m | +16.4% | -0.5% |
| 1y | -8.4% | +9.6% |
| ytd | -4.5% | +7.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PLTR Fundamental Analysis
Palantir's revenue trajectory is one of the most dramatic acceleration stories in large-cap software: Q3 2026 revenue reached $2.313 billion, up 95.87% year over year, building on a sequential climb from $1.633 billion in Q1 and $1.935 billion in Q2, with the prior-year Q3 base of just $1.181 billion. The growth is broad-based but increasingly commercial-led, with the Commercial segment at $1.168 billion edging past the Government segment's $1.146 billion for the first time — a milestone that diversifies the revenue base away from pure defense-budget dependence. However, the market's muted reaction to these results reflects concerns that remaining performance obligations were flat and total contract-value growth slowed sharply, raising the question of whether the current 96% growth rate is a peak rather than a plateau.\n\nProfitability has inflected powerfully: Q3 2026 net income was $1.128 billion (a 48.76% net margin) on a gross margin of 83.43%, with operating income of $1.085 billion representing a 46.89% operating margin. The multi-quarter progression is striking — net margin rose from 43.27% in Q4 2025 to 53.32% in Q1, 54.86% in Q2, and 48.76% in Q3, while gross margin has held in a tight 83–87% band, consistent with best-in-class software economics rather than the lower-margin consulting profile some critics allege. The slight sequential dip in net margin from Q2 reflects a higher tax and operating-expense base, but the company remains solidly and structurally profitable, a dramatic transformation from the loss-making years of 2021–2022.\n\nThe balance sheet is fortress-like: debt-to-equity is just 0.031, the current ratio stands at 7.11, and cash at the end of Q3 reached $3.653 billion, giving Palantir essentially no leverage risk. Free cash flow is prodigious — $4.054 billion on a trailing-twelve-month basis, with quarterly FCF of $1.197 billion in Q3, $1.202 billion in Q2, and $892 million in Q1 — and ROE of 22.0% and ROA of 17.3% confirm high capital efficiency. The one blemish is stock-based compensation of $318.9 million in Q3 alone, which, while down as a percentage of the now-massive revenue base, remains a real dilution consideration for shareholders.
Quarterly Revenue
$2.3B
2026-09
Revenue YoY Growth
+95.9%
YoY Comparison
Gross Margin
83.4%
Latest Quarter
Free Cash Flow
$4.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PLTR Overvalued?
Because Palantir is solidly profitable (Q3 net income of $1.128 billion), the PE ratio is the appropriate primary metric, and it is extreme: the trailing PE stands at 257.6x while the forward PE is 70.7x. That enormous gap implies the market expects earnings to roughly quadruple over the forward horizon — consistent with consensus EPS estimates of $14.38 against a trailing EPS of just $0.0039 — meaning the valuation is effectively a bet on flawless multi-year compounding rather than current earnings power.\n\nRelative to software-infrastructure peers, Palantir trades at a staggering premium: a PS ratio of 94.1x, an EV/Sales of 68.1x, a price-to-book of 57.0x, and an EV/EBITDA of 249.5x, all multiples that dwarf typical high-growth software averages in the 10–20x sales range. The premium is partially defensible given 96% revenue growth, 83% gross margins, and 36% net margins that few peers can match, but the PEG ratio of 1.13 is the one metric that looks almost reasonable — suggesting the valuation is expensive in absolute terms yet not obviously irrational when normalized for growth.\n\nHistorically, Palantir's own valuation band has been extraordinarily wide: PS ratio ranged from roughly 26x in late 2022 to over 365x in Q3 2025, and the current 94.1x sits well below that peak but far above the 2022–2023 trough. The trailing PE of 257.6x compares with a historical range from negative territory in 2022 to over 550x in Q4 2024, placing the current reading in the middle-to-lower portion of its own band — a sign that earnings growth is beginning to catch up to the multiple, even as the absolute level remains demanding.
PE
257.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 66x~290x
vs. Industry Avg
26.1x
Industry PE ~26.1x*
EV/EBITDA
249.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on valuation rather than solvency. Palantir carries debt-to-equity of just 0.031 and $3.653 billion of cash, so leverage is not a threat, but the 257.6x trailing PE and 94.1x PS mean the stock depends on continued hyper-growth to justify its price — any deceleration is punished disproportionately. The clearest warning sign is operational: Q3 remaining performance obligations were flat and total contract-value growth slowed sharply even as revenue grew 95.87%, which could signal that the current growth rate is a peak. Stock-based compensation of $318.9 million in Q3 is a further drag on per-share value, and revenue, while diversifying, remains concentrated in a relatively small number of large government and commercial contracts.
Market and competitive risks are dominated by multiple compression. At 68.1x EV/Sales versus a 10-20x norm for high-growth software, Palantir is priced for perfection, and the October 16 selloff in AI software valuations showed how quickly the sector can rotate away from premium names. The stock's beta of 1.61 means it amplifies market moves by roughly 60%, and it has already lagged the S&P 500 by 25.73 percentage points over the trailing year despite a 27.98% six-month gain. Competitive pressure from hyperscaler AI platforms and cheaper self-serve analytics tools threatens Palantir's high-touch model, while governance concerns cited by bearish analysts add a sentiment overhang that can accelerate de-rating episodes.
The worst-case scenario is a growth stall combined with multiple compression: flat RPO rolls into decelerating revenue, the market re-rates the stock toward peer multiples, and the shares retrace toward the $106.37 52-week low or the $80 analyst low target. From $175.40, a move to the 52-week low implies roughly -39%, while the $80 bear target implies about -54%. The stock's demonstrated 48.22% maximum drawdown shows this is not a theoretical exercise — it has happened before, and with beta at 1.61 a broader risk-off rotation in AI software would likely trigger it again.
FAQ
The most severe risk is valuation compression: at 94.1x sales and 257.6x trailing earnings, any growth disappointment is amplified, and the stock has already demonstrated a 48.22% maximum drawdown. Second is a bookings slowdown — Q3 remaining performance obligations were flat and total contract-value growth slowed sharply even as revenue grew 95.87%, which if confirmed in Q4 would force consensus revenue cuts and a re-rating toward peer multiples. Third is market and sector risk: beta of 1.61 makes PLTR roughly 60% more volatile than the S&P 500, and the October 16 AI-software selloff showed how quickly capital rotates out of premium names; the stock has lagged the S&P 500 by 25.73 percentage points over the trailing year. Fourth is company-specific dilution and governance: stock-based compensation of $318.9 million in Q3 alone, shares outstanding rising from 2.304 billion in Q4 2024 to 2.406 billion in Q3 2026, and governance concerns cited by bearish analysts including RBC's Underperform rating. Ranked by severity, valuation compression and bookings deceleration are the two that could most plausibly turn the bear case into reality.
The 12-month forecast splits into three scenarios. The base case carries 50% probability with a $195–$220 range, assuming revenue growth moderates toward 50–70%, gross margin holds above 80%, operating margin above 40%, and the stock converges toward the $216.00 analyst average through earnings growth rather than multiple expansion. The bull case carries 25% probability with a $230–$265 range, requiring Q4 RPO and contract-value re-acceleration, additional sovereign-AI wins, and commercial growth above 100%, carrying the stock to Goldman Sachs' $230 target and the $265 Street high. The bear case carries 25% probability with an $80–$130 range, triggered by flat RPO confirming a bookings peak, revenue growth decelerating to 30–40%, and a re-rating toward 20–30x sales. The base case is the most likely outcome, and its key assumption is that the Q3 bookings deceleration proves to be a blip rather than the start of a slowdown — if that assumption fails, the probability mass shifts decisively toward the bear case.
PLTR is fairly valued to modestly overvalued on an absolute basis, though not obviously irrational once adjusted for growth. The primary metrics are extreme: 94.1x price-to-sales, 68.1x EV/Sales, 57.0x price-to-book, 249.5x EV/EBITDA, and 257.6x trailing PE, all multiples that dwarf the 10–20x sales range typical of high-growth software peers. The one metric that argues the premium is earned is the PEG ratio of 1.13, which normalizes the multiple against a 95.87% growth rate, and the gap between the 257.6x trailing PE and 70.7x forward PE shows the market expects earnings to roughly quadruple toward consensus EPS of $14.38. Against its own history, the current 94.1x PS sits well below the 2025 peak above 365x but far above the 2022–2023 trough near 26x, placing it in the middle of an extraordinarily wide band. The market is effectively pricing in sustained 50%+ growth with 80%+ gross margins — anything less is what would make the stock look expensive in hindsight.
From a pure risk/reward standpoint, PLTR at $175.40 offers roughly 23% upside to the $216.00 average analyst target but roughly 39% downside to the $106.37 52-week low and about 54% downside to the $80 low target, so the magnitude asymmetry is unfavorable even though the probability-weighted base case (50%, $195–$220) is constructive. The business quality is not in question — 95.87% revenue growth, 83.43% gross margin, 48.76% net margin, and $4.054 billion of TTM free cash flow are elite — but 94.1x sales and 257.6x trailing earnings mean you are paying today for years of flawless execution. The 22 Buy / 9 Hold / 2 Sell split and 1.85 recommendation mean confirm the Street likes the company but will not chase the stock, and the flat Q3 RPO is a genuine yellow flag on forward bookings. It is a reasonable buy for a long-horizon growth investor who sizes the position small and accumulates on weakness toward the $140–$150 zone (roughly 60–65x sales), and a poor buy for anyone who needs near-term downside protection or income.
PLTR is structurally a long-term holding but tactically a difficult short-term trade. The long-term case rests on a genuine growth stage — revenue nearly doubled year over year to $2.313 billion in Q3 2026, commercial revenue surpassed government for the first time at $1.168 billion versus $1.146 billion, and U.S. revenue grew 119% — with high earnings visibility from multi-year government and enterprise contracts and a fortress balance sheet (debt-to-equity 0.031, current ratio 7.11, $3.653 billion cash). The short-term case is much weaker: beta of 1.61, a 48.22% maximum drawdown, a 7.07% one-month decline versus the S&P 500's -1.99%, and event risk around every quarterly bookings print make it a poor vehicle for traders without strict stop discipline. There is no dividend (payout ratio 0), so all return must come from price appreciation. A suggested minimum holding period is three to five years, sized small enough to survive a retest of the $106.37 52-week low, with accumulation favored on pullbacks toward $140–$150.

